We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Glenmark Pharmaceuticals Seeks Rehearing After Losing Tarka Patent Ruling
The item has been added to your shopping cart.
Glenmark Pharmaceuticals Seeks Rehearing After Losing Tarka Patent Ruling
Generic firm Glenmark Pharmaceuticals wants a federal appeals court to rehear its case over rights to the combination hypertension drug Tarka, arguing that an April decision was invalid because it incorrectly attributed exclusive patent rights.